COVID Vaccine Skepticism Censored After Virality Project Complained to Social Media

A Stanford University group helped the United States government censor COVID-19 dissidents, then they lied about it. The Twitter files published by journalist Matt Taibbi in March revealed the Stanford’s Internet Observatory initiative, also known as the Virality Project, pushed platforms to treat user concerns about vaccine mandates as disinformation and to consider stories of true vaccine side effects to be actionable content on social media.

CDC Reports Largest Increase in U.S. Infant Mortality Rate in Two Decades~15-Month-Old Girl Dies Two Days After ‘Well-Baby Visit’ Vaccinations

The United States is seeing an increase in infant deaths. That’s the headline from a new report from the CDC. It says there’s been a year-to-year increase in the infant mortality rate—the first in about 20 years. The report caused concern at the CDC. They’re worried that the back-to-back increase might become a trend. … Losing a child is a terrible grief that more and more parents are experiencing in the U.S., according to new data from the CDC. The report shows the infant mortality in 2021 was 5.44. In 2022, it was 5.6—a three percent increase.


15-Month-Old Girl Dies Two Days After ‘Well-Baby Visit’ Vaccinations

Melody Rain

A 15-month-old girl died in Warwick, New York on Oct. 19, 2023, two days after receiving three shots of five vaccines during a routine well-baby visit with a pediatrician at the Herbert Kania Pediatric Group. Melody Rain Palombi-Malmgren was a “perfectly healthy child,” according to her mother, Katherine Palombi. She was administered varicella (chickenpox), DTaP (Diphtheria, Tetanus, and acellular Pertussis) and Hib (Haemophilus influenzae type b bacteria) on Oct. 17, and two days later suffered a heart attack and stopped breathing.1 2 3 4 5 6 7 8

Hospital records show that the child also suffered liver and kidney failure.1 2 5

Melody was being cared for by her grandmother when her symptoms began. The grandmother called Palombi and told her that Melody was having trouble breathing. “I just kept saying, she just had vaccines, she just had vaccines,” Palombi recalls.1 2 3 4 5 8

The grandmother then called 911 and was instructed to perform CPR until the paramedics could arrive. Melody was subsequently transported by ambulance to St. Anthony’s Community Hospital where EMTs and medical staff tried unsuccessfully to resuscitate her.3 4 5 8

“By the time I got to the hospital, they put me in a room,” Palombi said, “and they just kept saying, ‘We’re working on her.’”3 5

“They were going over everything from that morning because she’d gotten into something,” she said, and “I just kept saying, ‘She had vaccines. A couple of days before this, she had vaccines.’”3 5

Child Had Previously Been Hospitalized Soon After Vaccinations

Palombi said that her daughter had been hospitalized before with a fever of 104° and a body rash all over her body that she developed within 24 hours after being vaccinated when she was two months old. Palombi said that the doctors had told her they did not think the symptoms were an allergic reaction to the vaccines but rather were caused by a virus. But she believes that, in both cases, the vaccines were too much for her daughter’s body.1 3 4 5

Palombi said she believed the five vaccines her daughter got were too much for her daughter’s body to handle. In an interview with News 12 Westchester, Palombi advised other parents, “Trust your gut and don’t let them push anything on to your children that you don’t want to do.”1 3 4 5

The U.S. Centers for Disease Control and Prevention (CDC) recommends a total of 10 shots of 16 vaccines for a 15-month-old child. In addition to the ones Melody received, the CDC recommends  the following shots: the HepA (Hepatitis A), Influenza, MMR (Measles, Mumps, and Rubella), PCV (Pneumococcal Conjugate Vaccine), IPV (Inactivated Polio Vaccine) RV (Rotavirus Vaccine) and COVID-19.9

“I just want to spread awareness in Melody’s name,” Palombi said. “Maybe she can save other children.”1 3 4 5

In an interview with The Defender, Palombi recounted how a mother had recently reached out to her when her two-month-old child suffered a reaction to a vaccine…

The baby was passing blood in the stool and everything else. So I told her, ‘You need to get the baby back to the emergency room immediately.’ And she did. The pediatrician admitted to this mom, ‘If you didn’t bring the baby in, the baby would have been dead by Monday.’3

Palombi also recalled how another woman had reached out to her to share how her grandson had died at six months old following a well-baby visit. “They told her it was SIDS,” she said. “That’s not what it is. It’s so sad to keep hearing that I’m not the only one.”3

“I just want to keep educating parents on the dangers of vaccines, encourage them to spread them out, give them when the child is older, or get tested for the [methylenetetrahydrofolate reductase] gene,” Palombi said. Some physicians believe that the “MTHFR” gene places certain children at higher risk for serious reactions to vaccines.3

If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here.

Click here to view References:



Fauci-Run Lab In Montana Experimented With Coronavirus Strain From Wuhan A Year Before Pandemic

Director Anthony Fauci speaks during the daily press briefing. (Photo by JIM WATSON/AFP via Getty Images)

OAN’s Brooke Mallory
12:48 PM – Friday, November 3, 2023


Republished below in full unedited for informational, educational, & research purposes.

A recent investigation has revealed that coronaviruses from the Chinese facility in Wuhan, which is now understood to be the origin of the COVID-19 pandemic, were experimented with a little over a year before the worldwide pandemic. These efforts were also funded by U.S. taxpayers.

In 2018, a “SARS-like” virus known as WIV1 was introduced in a lab in Montana, infecting 12 Egyptian fruit bats under the direction of Dr. Anthony Fauci of the National Institutes of Health.

The WIV1 coronavirus was reportedly tested on bats obtained from a “roadside” Maryland zoo and was transported from the Wuhan facility, where the FBI now suspects the COVID-19 pandemic originated.

According to data that was made public this week by a campaign organization, the unique virus was unable to generate a “robust infection.”

However, the study provides additional proof of the connections between the U.S. government, the Wuhan lab, and the tax-payer-funded risky virus research.

In 2018, the publication of the study was completed, showing that the “SARS-Like Coronavirus WIV1-CoV Does Not Replicate in Egyptian Fruit Bats.” DRASTIC, an online activist organization that looks into the origins of COVID-19 and the lab leak scenario, initially brought attention to the study.

The White Coat Waste Project (WCW), a watchdog group, is currently requesting further information on the experiment under the Freedom of Information Act. The group has been campaigning to prevent American tax funds from being sent abroad to finance controversial virus research.

The 2018 study was conducted under the direction of Fauci, the former head of the National Institutes of Allergy and Infectious Diseases, at the NIH’s Rocky Mountain Laboratories in Montana. Ralph Baric of the University of North Carolina, a partner with the Wuhan Institute of Virology, and the NIH’s Rocky Mountain Laboratories also collaborated on the study.

Twelve Egyptian fruit bats were taken from a Maryland zoo by scientists, who then injected the animals with the WIV1-coronavirus, which was initially identified in Chinese rufous horseshoe bats.

Every day, they examined the bats and took their temperatures and body weights. Researchers also collected samples from the mouths and nostrils of the animals.

Four of the bats were put to sleep on days three, seven, and 28, and their heart, liver, kidney, spleen, bladder, reproductive organs, eyes, and brain were taken out for examination. Antibodies and white blood cell counts were also examined by researchers.

The WIV1-coronavirus did not create “a robust infection,” according to the researchers, who also found “very limited evidence of virus replication.”

The WCW said that the zoo’s curator and director of animal health, who had previously worked at the NIH’s own animal testing labs from 2003 to 2012, had shipped the bats from a “roadside” Maryland zoo to the Montana facility.

The Catoctin Wildlife Preserve (CWP), which is situated in Thurmont, Maryland, less than 15 minutes from Camp David, has a history of violating animal welfare laws. In 2012, the CWP was fined $12,000 for providing subpar care and shelter for animals that was deemed unsafe and negligent.

As of April 2023, records indicate that of the 523 federally controlled creatures housed in the preserve, 241 were bats, 41 of which were Egyptian fruit bats.

“I left heartbroken and sad. The enclosures are so small and not well kept. This place is so unkempt. It’s awful. It needs to be shut down. You can see the pain in these animals eyes. Something has to be done about this place,” said one reviewer of the establishment.

The United States conducts the majority of gain-of-function virus research across the globe. In gain-of-function trials, pathogens are rendered more lethal or contagious.

Proponents of the experiments argue that they help scientists anticipate future outbreaks, while detractors contend that the hazards of a leak exceed any possible advantages. Due to these concerns, U.S. officials discreetly terminated a $125 million study last month that searched for novel viruses using public funding.

“Our investigation has uncovered the real-life horror story of how a shady roadside zoo whose curator was an NIH animal experimenter shipped off bats to a deadly government virus lab overseen by Dr. Fauci to be infected with a coronavirus obtained directly from the Wuhan lab that experts believe caused COVID,” said the founder of WCW, Anthony Bellotti.

Stay informed! Receive breaking news blasts directly to your inbox for free. Subscribe here.

Pfizer Implements $3.5 Billion Cost-Cutting Program Amid Lagging COVID Injection Sales

Pfizer Implements $3.5 Billion Cost-Cutting Program Amid Lagging COVID Injection Sales
AP Photo/Lynne Sladky
Pfizer’s latest COVID booster isn’t going super well. Only about 2% of the entire American population has been successfully injected, and it appears to not be in the cards that that figure will appreciably rise anytime soon. The “safe and effective” façade is wearing thin.

Pfizer is instituting a “cost realignment program” as a consequence, in an attempt to stem the bleeding for shareholders – the fiscal health of which, not actual health, is its only true passion.

Via Forbes (emphasis added):

Pfizer is implementing a “cost realignment program” expected to save the pharmaceutical giant at least $3.5 billion as it prepares for revenue drops for its Covid-19 vaccine and Paxlovid, a prescription pill for treating Covid-19, according to its updated full-year guidance…

The company also expects full-year revenues for its vaccine and Paxlovid to be about $12.5 billion—$9 billion lower than what was anticipated…

Paxlovid full-year revenue expectations were lowered by about $7 billion while vaccine revenue expectations were reduced by approximately $2 billion because of “lower-than-expected vaccination rates.”

The “lower-than-expected vaccination rates” were not for lack of trying on the part of the pharmaceutical-funded corporate state media, which launched an all-out terror campaign in August ahead of a mid-September booster rollout to force-feed more vaxxes to the public and justify new mandates in schools and offices.

RelatedMaking a Killing: Americans Shelling Out up to $190 for COVID Boosters

Anyway, here’s a better idea: let’s save Pfizer executives the fiscal trouble by confiscating their ill-gotten gains obtained through documented fraud, liquidating them and distributing them to the victims of their mandated shots, and then putting them on trial for their crimes, possibly using RICO statutes to do it. They deserve it way more than any mafia racket ever did.

The ”documented fraud” accusation isn’t just hyperbole. Pfizer and the Public Health™ authorities literally committed documented, provable fraud in multiple regards, including:

  • The organized demonization and suppression of effective pre-existing therapeutics like hydroxychloroquine and ivermectin, as their existence would preclude the emergency use authorization Pfizer and Moderna desperately needed to get their shots pushed through the regulatory process and into the market. If it were acknowledged that prior therapies existed, the COVID-19 shots would never have been mandated and, in fact, would not have even been available until they went through the same 10-15-year vetting process that every vaccine in history has gone through – by which time the cost-benefit analysis would have been much clearer to anyone paying attention and much harder to muddy by the media.
    Of course, Pfizer and the Public Health™ authorities knew very well that the inefficacies and dangers of their product would come to light and sales would suffer, assuming it ever made it to market in the first place – which it would not have were Pfizer unable to rig the trials.
  • Pfizer used a separate and significantly riskier manufacturing process for its publicly available shots than the one it used to get regulatory approval in the trials.
  • Pfizer gave its Australian employees a separate vaccine batch from the one distributed to the public.
  • Pfizer never bothered to test whether its leaky vaccine stopped transmission (it doesn’t) in its clinical trials, despite public proclamations to the contrary.

The $350 Billion COVID Bailouts of States Were Entirely Unncessary

Get Very Mad. The $350 Billion COVID Bailout of States Was Entirely Unncessary
AP Photo/Susan Walsh
We’re two years removed from the passage of the American Rescue Plan Act (ARPA), the $2 trillion “stimulus” measure that Congress passed in March of 2021, and the verdict on much of that spending can now be delivered.

The biggest line item in the bill was the $350 billion given to state and local governments to deal with revenue shortfalls and other pandemic-related expenditures — like golf courses.

But here we are two years later, and, astonishingly, only 45% of the $350 billion in funds to bail out states has been spent. Local governments had reported to the Government Accountability Office (GAO) that they spent just 38% of their funds received through ARPA.

“The new GAO study confirms that the ARPA spending was not needed,” Chris Edwards, chair of fiscal studies at the Cato Institute, tells Reason. “By the fall of 2020, it was clear that the states were in good fiscal shape and not facing Armageddon as many policymakers were claiming. They did not need federal handouts.”

It would be more accurate to say that most states did not need federal handouts. That was one of the primary objections to the bill. By March 2021, there may have been a dozen states — most of them blue states — whose finances were so mismanaged that it was possible that they would have to declare bankruptcy. Many states like Illinois, used the ARPA money to rescue their failing pension systems. Others spent the cash on frivolous extras.

Did the money do any good?


The effectiveness of that spending has been repeatedly called into question. In a National Bureau of Economic Research working paper published in June 2022, a trio of researchers found that pandemic-era aid distributed to state and local governments had cost taxpayers about $855,000 per job saved. The stimulus spending had only “a modest impact on government employment and has not translated into detectable gains for private businesses or for states’ overall economic recoveries,” concluded University of California, San Diego economists Jeffrey Clemens and Philip Hoxie and American Enterprise Institute senior fellow Stan Veuger, the paper’s three authors.

“Even the unstated assumption behind these handouts — that Washington should step in if there are dips in state revenue — is badly flawed,” wrote David Ditch and Richard Stern, policy analysts at the Heritage Foundation. “Many states are fiscally mismanaged, and federal bailouts enable them to avoid much-needed discipline.”

Tourism is nice and roads are in some ways an essential government function, but the emergency COVID spending was meant to help states address an immediate public health crisis—or to offset the costs of it. It’s not at all clear how highway construction was a victim of the pandemic, and “travel marketing” is something that shouldn’t be funded with taxpayer dollars no matter where they come from.

If there ever was a need for emergency aid to states and localities, it has obviously long since passed. Edwards points out that state and local tax revenue in the first quarter of 2023 was up 25 percent over the first quarter of 2020—which immediately preceded the onset of the pandemic.

Perhaps a lot of those states should give the unspent money back to the U.S. treasury.

National Vaccine Information Center (NVIC): ACIP Recommends RSV Vaccination for Pregnant Women

ACIP Recommends RSV Vaccination for Pregnant Women

By Theresa Wrangham
Published September 28, 2023 in Government
SEE:;Republished below in full unedited for informational, educational, & research purposes.

Pfizer’s Abrysvo Respiratory Syncytial Virus (RSV) vaccine was recommended by the CDC's Advisory Committee on Immunization Practices (ACIP) on Friday, Sept. 22, 2023. The recommendation is to administer the vaccine only during the RSV season of September through January in pregnant women at 32 to 36 weeks of gestation. Abrysvo was approved in August for use in pregnant women to prevent RSV in infants by the FDA.1

The ACIP also approved the use of taxpayer dollars in the Vaccines for Children Fund (VFC) for Abrysvo so that the vaccine may be administered “free of charge” in many settings. The CDC is expected to accept the ACIP’s recommendation and add this vaccine to the adult schedule.

The ACIP also stated that generally, infants born to mothers who had been vaccinated for Abrysvo should not receive the newly recommended RSV monoclonal antibody nirsevimab, known as Beyfortus. This statement would seem to fly in the face of ACIP’s lack of concern in August regarding vaccine coadministration, which was justified by the committee noting that nirsevimab was a drug and not a vaccine.2

Yet Another Pricey RSV Intervention Expensive RSV Interventions

One constant for the ACIP was their continued unhappiness with the price tag for  RSV interventions. The nirsevimab RSV monoclonal antibody costs $395-$495 per dose3 and Abrysvo RSV vaccine costs  $295 per dose. When questioned by the committee about pricing outside the U.S., Pfizer didn’t provide specifics and instead stated that a tiered pricing strategy based on estimated affordability is used. 

Notably, the vaccine and monoclonal antibody offer limited protection to infants from RSV - about six months.4 5 6

RSV Vaccination Timing Hoped to Curtail Premature Births

Shifting the vaccination window to 32-36 weeks into a pregnancy is later than the clinical trial window considered by the FDA. Tables comparing outcomes for vaccines administered at 24-31 weeks vs. 32-36 weeks appeared to decrease preterm births. However, due to fewer study subjects, the data is likely to be underpowered, and real-world results for premature births in RSV-vaccinated women could differ. Notably, this clinical trial data reflects outcomes for only healthy, low-risk pregnancies.

Clinical Trail Data and Adverse Vaccine Events to be Monitored Pregancy & Vaccines

Vaccine safety monitoring for Abrysvo vaccine adverse events will be done through the CDC’s Vaccine Safety Datalink, the federal Vaccine Adverse Event Reporting System (VAERS), and V-safe.

A higher rate of Guillain-Barre Syndrome (GBS), a rare but serious neurological disorder that causes inflammation of the peripheral nerves,7 was reported among individuals who received the vaccine in clinical trials for Abrysvo. There was also a higher rate of atrial fibrillation, a serious heart disorder that may lead to complications such as stroke, heart attack, or heart failure,8 among vaccine recipients.9

In pregnant women clinical trials also revealed higher rates of preterm deliveries, as well as higher rates of pre-eclampsia, a complication of pregnancy with symptoms that include high blood pressure, swelling of the hands and feet, and protein in the urine and gestational hypertension, in women vaccinated with Abrysvo versus those not vaccinated.10

Conditions to be monitored include many neurologic, neuroinflammatory, and cardiac conditions such as GBS, acute disseminated encephalomyelitis (ADEM), multiple sclerosis, meningitis, transverse myelitis (TM), chronic inflammatory demyelinating polyneuropathy (CIDP), atrial fibrillation, and supraventricular tachycardias (SVT).

Pregnancy Vaccination Recommendations Increase as Flu Season is Rebranded

Abrysvo is the fourth vaccine to be recommended for use by the ACIP. Adverse event reports submitted for Abrysvo could also potentially be in connection with the coadministration of COVID-19, influenza, and TdaP vaccines.11

As seasonal COVID-19, influenza, and RSV vaccines are rolled out, what has previously been marketed as flu season has been rebranded as respiratory season to harmonize the push for the uptake of these seasonal vaccines.12

Vaccine Injury Compensation and RSV

The ACIP’s recommendation of Abrysvo RSV vaccine for pregnant women is one of the steps required before the vaccine is covered by the federal Vaccine Injury Compensation Program (VICP).13

Last month, the ACIP approved the drug nirsevimab, as if it were a vaccine and it too may eventually be covered by the VICP.14

About RSV & RSV Vaccine ill infant

RSV is a common and highly contagious respiratory virus that produces cold symptoms such as coughing, sneezing, wheezing, decreased appetite, and fever. Most people who become infected with RSV will recover fully within a week or two without treatment.15

Young infants and children, older adults, and individuals with immune system disorders and chronic health conditions are at an increased risk of RSV infection and may also be at an elevated risk of developing complications from the illness.16 Complications of RSV infection include inflammation of the small airways within the lungs (bronchiolitis) and lung infection (pneumonia) and may require hospitalization for supportive care.17

To learn more about RSV and RSV vaccines and their complications and risks, visit NVIC’s RSV web pages.


1 U.S. Food & Drug Administration. FDA Approves First Vaccine for Pregnant Individuals to Prevent RSV in Infants.

2 Wrangham T. Vote to Add Drug to Childhood Vaccination Schedule Opens Door to Daycare Mandates, Tracking, and Injury Liability Shield. National Vaccine Information Center Aug. 10, 2023.

3 Wrangham T. Vote to Add Drug to Childhood Vaccination Schedule Opens Door to Daycare Mandates, Tracking, and Injury Liability Shield. National Vaccine Information Center Aug. 10, 2023.

4 Ortega-Sanches IR. ACIP Presentation - Economics of Vaccinating U.S. Adults ≥60 years old against Respiratory Syncytial Virus. U.S. Centers for Disease Control and Prevention Feb 23, 2023.

5 Armstrong M. Nirsevimab data leave the door open for Pfizer. Evaluate Vantage Mar. 3, 2022.

6 Griffin MP, Yuan Y, Takas T, et al. Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants. N Engl J Med. Jul 30, 2020; 383(5):415-425.

7 Wrangham T. ACIP: 2018-2019 Flu Vaccine 44 Percent Effective. National Vaccine Information Center Apr. 7, 2019.

8 NIH National Library of Medicine. Atrial Fibrillation. MedlinePlus Aug. 22, 2023.

9 US Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee February 28 - March 1, 2023 Meeting Briefing Document- FDA: Applicant- GSK. March 1, 2023.

10 Pfizer. Bivalent RSV Prefusion F Vaccine for Maternal Immunization to Protect Infants. Presentation to the Vaccines and Related Biological Products Advisory Committee Meeting. May 18, 2023.

11 U.S. Centers for Disease Control & Prevention. Vaccines During and After Pregnancy. Nov. 9, 2021.

12 U.S. Centers for Disease Control & Prevention. Respiratory Disease Season Outlook. Sept. 14, 2023.

13 U.S. Health Resources & Services Administration. Email Correspondence - EUA Vaccines and VICP. National Vaccine Information Center Aug. 24-30, 2021.

14 Wrangham T. Vote to Add Drug to Childhood Vaccination Schedule Opens Door to Daycare Mandates, Tracking, and Injury Liability Shield. National Vaccine Information Center Aug. 10, 2023.

15 U.S. Centers for Disease Control and Prevention. Symptoms and Care. Aug. 16, 2023.

16 Jha A, Jarvis H, Fraser C, et al. Respiratory Syncytial Virus. June 1, 2016.

17 US Centers for Disease Control and Prevention. RSV in Infants and Young Children. Aug. 4, 2023.

Fauci Had Secret Meeting With The CIA Regarding COVID-19 Origins

Fauci ​​Had Secret Meeting With The CIA Regarding COVID-19 Origins

Director of the National Institute of Allergy and Infectious Diseases Anthony Fauci looks on during the daily briefing on the novel coronavirus, COVID-19, in the Brady Briefing Room at the White House on April 1, 2020, in Washington, DC. (Photo by Mandel NGAN / AFP) (Photo by MANDEL NGAN/AFP via Getty Images)

OAN’s Elizabeth Volberding
1:05 PM – Tuesday, September 27, 2023


Republished below in full unedited for informational, educational, & research purposes.

Anthony Fauci, the former chief White House medical advisor, secretly visited the Central Intelligence Agency (CIA) headquarters to “influence” the outcome of the agency’s investigation into the origins of COVID-19 during the pandemic, according to the Republican chairman of the House coronavirus panel.

Representative Brad Wenstrup (R-Ohio), the head of the House Select Subcommittee on the Coronavirus Pandemic, uncovered “concerning information” that was retrieved through his panel in a letter he sent to the Inspector General (IG) of the United States Department of Health and Human Services (HHS), Christi Grimm.

On Tuesday, the letter was publicized.

Allegedly, the letter “lends credence to heightened concerns about the promotion of a false COVID-19 origins narrative by multiple federal government agencies.” 

“According to information gathered by the Select Subcommittee, Dr. Anthony Fauci, then-director of National Institute of Allergy and Infectious Diseases, played a role in the Central Intelligence Agency’s review of the origins of COVID-19,” Wenstrup wrote. “The information provided suggests that Dr. Fauci was escorted into CIA Headquarters — without a record of entry — and participated in the analysis to ‘influence’ the Agency’s review. Our goal is to ensure the scientific investigative process regarding the origins of COVID-19 was fair, impartial, and free of alternative influence.”

It remains unknown who revealed the information to the subcommittee. However, the letter references one individual, Special Agent Brett Rowland, and requests that the IG make him available for a “voluntary transcribed interview.”

The specific date of Fauci’s undisclosed visit to the CIA headquarters in Langley, Virginia, was not mentioned in Wenstrup’s letter to Grimm.

“The American people deserve the truth — to know the origins of the virus and whether there was a concerted effort by public health authorities to suppress the lab leak theory for political or national security purposes,” Wenstrup announced in a statement, requesting information related to the “movements of Dr. Fauci throughout the pandemic.”

“In addition to these documents, we request you make HHS Special Agent Brett Rowland available for a voluntary transcribed interview at a date to be determined,” Wenstrup said. 

Wenstrup searched for documents and communications between the HHS, the National Institute of Allergy and Infectious Disease, and the U.S. Marshals Service. The sought-after documents were reportedly meant to protect Fauci, and its information also pertains to the former White House coronavirus czar’s admittance or entry into any CIA-owned, operated, or occupied buildings. 

“This allegation is the latest distraction put forth by House Republicans after months wasting taxpayer dollars on seemingly endless conspiracy theories, all while failing to produce any new evidence related to the origins of COVID-19,” a spokesperson for the HHS told Newsweek via email.

In February, reports stated by the Department of Energy and FBI explained that the virus most likely stemmed from a lab leak at Wuhan. However, Fauci, 82, strongly advised that the lab leak theory was “inaccurate.”

“You have to look at the data. I don’t see any data for a lab leak,” Fauci stated. “That doesn’t mean it could not have happened, and that’s the reason I always keep an open mind about that.”

A document request from the coronavirus subcommittee, with an October 10th deadline, requests the following.

  • Any documents authorizing, supporting, or affiliated with Fauci’s claimed movements into any CIA-owned, operated, or occupied buildings between January 1st, 2020, and December 31st, 2022.
  • Any documents and communications between or among contractors and employees of Health and HHS and the IG regarding Fauci’s whereabouts as it pertains to the CIA.
  • Any documents and communications between or among contractors and employees of HHS and the IG and employees or contractors of the U.S. Marshals Service regarding Fauci and the CIA entry.
  • Any documents and communications between or among contractors and employees of HHS and the IG and employees or contractors of the NIH and NIAID.

Stay informed! Receive breaking news blasts directly to your inbox for free. Subscribe here.

Fauci Has $11.5 Million Net Worth After Leaving Government Position

Fauci Has $11.5 MILLION Net Worth After Leaving Government Position

WASHINGTON, DC - MAY 11: Director of National Institute of Allergy and Infectious Diseases Anthony Fauci testifies during a hearing before the Labor, Health and Human Services, Education, and Related Agencies of House Appropriations Committee at Rayburn House Office Building on Capitol Hill May 11, 2022 in Washington, DC. The subcommittee held a hearing to examine the FY 2023 budget request for the National Institutes of Health. (Photo by Alex Wong/Getty Images)
Director of National Institute of Allergy and Infectious Diseases Anthony Fauci testifies during a hearing before the Labor, Health and Human Services, Education, and Related Agencies of House Appropriations Committee at Rayburn House Office Building on Capitol Hill May 11, 2022 in Washington, DC. (Photo by Alex Wong/Getty Images)

OAN’s James Meyers
3:07 PM – Tuesday, September 19, 2023


Republished below in full unedited for informational, educational, & research purposes.

A new report revealed that Dr. Anthony Fauci and his wife, Christine Grady, have a net worth of at least $11 million after he recently stepped down as the director of the National Institute of Allergy and Infectious Diseases (NIAID). 

According to a National Institutes of Health (NIH) termination report obtained by Fox News, it showed that the married couple are now holding $11.5 million in assets. 

The wealth comes from “awards, federal compensation increases, royalties, and mutual fund investments,” he claims.

However, Fauci previously asserted that he donates all of his royalties to charity. 

During his tenure as chief medical adviser to President Joe Biden and as a member of the White House Coronavirus Task Force under 45th President Donald Trump, Fauci made more money than both presidents.

He was also the highest-paid federal employee during the COVID-19 pandemic and retired with a salary of almost $481,000 a year, according to Fox.

Additionally, an investigation by the taxpayer watchdog found that the married couple received a net worth increase of $5 million between January 2019 and December 2021, which was up from $7.5 million. 

In 2021, Fauci was handed $1 million from at least one nonprofit, the Dan David Foundation, for “speaking truth to power” and “defending science” under Trump.

“Despite being viewed as a lifelong public servant, Dr. Fauci and his wife Christine Grady — who still remains among NIH leadership today — managed to become decamillionaires,” OpenTheBooks CEO Adam Andrzejewski told The New York Post.

“It came through a mix of decades-long tenure and special assignments that added to Fauci’s salary, as well as awards, payments, and perks from private entities,” he said. “Even though Fauci left his federal position, taxpayers funded and guaranteed a lifetime pension payout that we estimate rivals the president’s salary.”

Recently, Fauci joined the staff at Georgetown University, taking on a professor position at the Infectious Diseases Division in its School of Medicine.

“This is a natural extension of my scientific, clinical, and public health career, which was initially grounded from my high school and college days where I was exposed to intellectual rigor, integrity, and service-mindedness of Jesuit institutions,” Fauci said in a June press release.

Stay informed! Receive breaking news blasts directly to your inbox for free. Subscribe here.

Here’s Why You May Want to Think Twice Before Getting the Updated COVID Vaccine

Here's Why You May Want to Think Twice Before Getting the Updated COVID Vaccine
AP Photo/Charles Krupa, File
There’s an election coming up next year, so naturally, we’re all being conditioned for a return of COVID-19. For weeks, there’s been talk of a new COVID variant, which prompted Joe Biden to request more funding for Big Pharma a new, updated vaccine. Conveniently enough, at the same time, the media started reporting on the alleged increase in COVID-19 hospitalizations, and some high-profile people suddenly caught COVID, including Jill Biden.

The message was clear: be afraid of the return of COVID. Be very afraid.

But is that really what you should be afraid of? As you may recall, during the pandemic, we learned that the vaccines didn’t necessarily protect people from COVID-19, prompting widespread skepticism. Heck, the CDC even changed the definition of vaccine to remove references to immunity. Even though you may have decided that you weren’t going to get this updated vaccine, Biden floated the idea of a new vaccine mandate.

It seems likely that the Biden administration will do whatever it can to ensure demand for this updated vaccine, which has already been approved by the FDA for all Americans six months and older. According to Johns Hopkins professor Dr. Marty Makary, this new vaccine was approved by the FDA despite any human trial data.

Related: Is This Why We’re Being Conditioned for a COVID Comeback?

“They are telling every American six months of age and older to get this new COVID vaccine, but they approved it based on almost no data,” Makary told Guy Benson on his radio show. “There’s no human clinical trial data. Pfizer submitted data on ten mice, and Moderna, which also got a new vaccine approved [sic]. This is not an additional booster. This is an entirely newly designed COVID-19 vaccine they want everyone to get, even if you had COVID a few months ago. They don’t care. They’re pushing it hard.”

Even worse, the Biden administration appears ready to push this untested vaccine on children, who, we’ve pointed out many times, aren’t really at risk from COVID.

“And the White House bought four times as many doses for children this round as they did last fall when they had that new Bivalent vaccine. So this is a big push now of the Moderna trial. It turns out if you actually look at the data returned, they [Moderna] did give it to 50 people back four months ago. One of them had an adverse event requiring medical attention.”

So Pfizer has no human trial data for its new vaccine, and Moderna is being mum about the adverse effects of its new vaccine. How can they get away with this? Well, as Makary pointed out, they’ve gamed the system before.

Related: Biden Can Shove His New Vaccine Mandate up His Donkey

“They know that the regulatory process to get this approved is totally greased,” Makary pointed out. “President Biden was out there saying that this thing works and everyone needs to get it before the FDA even, you know, approved it. So this thing was greased.”

Imagine a vaccine where 1 in 50 doses resulted in an adverse effect. That’s the kind of result that, in the past, would guarantee rejection from the FDA. Heck, the Biden administration put a pause on the Johnson & Johnson COVID vaccine over a one-in-a-million risk of blood clots. Consider the evidence, and ask yourself why the Biden administration is pushing you to get an updated vaccine that hasn’t been thoroughly tested to protect yourself from a virus that isn’t nearly as severe as it was two years ago.

Nice Timing: Jill Biden Tests Positive for COVID

Nice Timing: Jill Biden Tests Positive for COVID
AP Photo/Susan Walsh
The media is in fearmongering mode; in recent weeks, we’ve been told about a new COVID-19 variant, a new vaccine in the works, and a potential new mandate. Dr. Anthony Fauci has been resurrected, telling the public that studies that dispute the effectiveness of masks are wrong and that if the CDC recommends masking again, they are right.

Many have observed that it appears the public is being conditioned for the return of the pandemic and all the terrible memories from those dark days: masking, social distancing, vaccine mandates, shutdowns, and, for good measure, illegal changes to election laws for your safety.

Related: Here’s This Month’s Trove of Censored COVID Articles

So when the news dropped that Jill Biden, the wife of and personal handler for Joe Biden, tested positive for COVID-19, my first thought was, “Of course she did; why didn’t I see that coming?” It was inevitable.

Her Communications Director Elizabeth Alexander released a statement Monday evening.

“This evening, the First Lady tested positive for COVID-19,” the statement read. “She is currently experiencing only mild symptoms. She will remain at their home in Rehoboth Beach, Delaware.”

According to reports, she’s double-vaccinated and double-boosted and previously caught COVID a year ago. So far, Joe Biden remains in the clear.

“Following the First Lady’s positive test for COVID-19, President Biden was administered a COVID test this evening,” White House Press Secretary Karine Jean-Pierre said in a statement released to the media. “The President tested negative. The President will test at a regular cadence this week and monitor for symptoms.”

Even before this latest development, many suspected that a psyop was afoot, and Jill Biden testing positive has affirmed that suspicion. Naturally, the liberal media was quick to poopoo such “conspiracy theories” and insisted that COVID is a growing problem again.

However, the announcement of the First Lady’s infection comes amid a spike in infections in the U.S. spurred on by the emergence of two new variants of the virus, prompting speculation that fresh COVID restrictions could be on the horizon.

In the week to August 19, there were more than 15,000 hospitalizations due to COVID-19 infections across the U.S., the most recent monitoring figures from the Centers for Disease Control and Prevention (CDC) show—a rise of nearly 19 percent on the week prior.

Admissions have been steadily rising since July, but are far below the highest peaks of the pandemic and appear to be localized into hotspots. A CDC spokesperson told Newsweek on Thursday it currently has no intention to call for a return of mandated mask-wearing, but didn’t deny that this might change if cases of the new variants were to rise significantly.

Newsweek then went on to dismiss the “conspiracy theories” of various right-leaning voices arguing that we’re being primed to go back to pandemic mode soon because of the new COVID variant. But we all know what has happened to “conspiracy theories” in the recent past, don’t we?

U.S. Taxpayers Fund $5 Billion Project NextGen to Develop Novel COVID Vaccines and Drugs

more money for more COVID vaccines

Just three months after the Biden administration announced that U.S. taxpayers would fund a $5 billion initiative called Project NextGen to develop “next generation” COVID-19 vaccines and therapeutics, the U.S. Department of Health and Human Services (HHS) awarded $1.4 billion in contracts under the program on Aug. 22, 2023. The total includes “$1 billion for COVID vaccine clinical trials, $326 million to create a new COVID monoclonal antibody drug, and $100 million to develop novel COVID vaccines and therapeutic technologies.”1 2 3

The HHS awards come on the heels of Pfizer implementing cost-cutting measures after sales for its Comirnaty messenger RNA (mRNA) COVID biologic and Paxlovid, a protease inhibitor drug, saw sharp declines this year. After Pfizer’s COVID products underperformed in 2023, the company predicted a rise in infection rates this fall that will inform its future sale strategy in the COVID market as it transitions from a government-dominated sales market to a commercial one.

However, reported cases of new SARS-CoV-2 infections in the U.S. have been rising sooner than expected, with public health officials tracking three new SARS-CoV-2 variants, including EG.5, FL.1.5.1, and BA.2.86. Coinciding with Project NextGen, the latest surge in COVID cases has led some universities and companies to reinstate the mask mandates in yet another repeat effort to “slow the spread” of the new SARS-CoV-2 variants. 3

Mask Wearing Reduced the Risk of Coronavirus Infection and Death by Only Five Percent

Throughout the pandemic, health officials in countries have been divided over whether face coverings effectively prevent the transmission of SARS-CoV-2 infections. Research conducted by Cochrane of London, England has provided substantial evidence to resolve this uncertainty. The Cochrane analysis of 78 global studies involving over one million people published on Jan. 30, 2023, found that masks only reduced the risk of SARS-CoV-2 infection and death by a mere five percent, and authors asserted that the benefits of mask-wearing and mask mandates did not outweigh the risks, such as impeding children’s academic and cognitive development in their early years.4

Considered the “gold standard” in assessing evidence-based medicine and public health policies, Cochrane reviews follow a rigorous methodology, are generally less vulnerable to bias, and only consider high-quality evidence in their systematic reviews that investigate the effects of interventions for disease prevention, treatment, and rehabilitation.5

In response to Cochrane’s new findings, Francois Balloux, PhD, director of the UCL Genetics Institute and professor of computational biology at University College London, wrote:

Irrespective of the limitations of the study, its results indicate that the true impact of medical/surgical masks and N95/P2 respirators on the transmission of respiratory viruses is at best small. 6

Other key findings by Cochrane included: there were no clear differences between the use of medical/surgical masks compared with N95/P2 respirators in healthcare workers when used in routine care to reduce respiratory viral infection; and community mask-wearing makes little to no difference in lab-confirmed infections, compared to not masking. However, the authors concluded that immunocompromised or vulnerable individuals may benefit from mask-wearing, since interventions that are not effective at a population level may still provide a personal benefit to at-risk individuals.

Vaccine Failure Persists as CDC Suggests New Variants May Evade Natural and Vaccine-Acquired Immunity

Health authorities warn that the highly mutated BA.2.86 lineage of coronavirus may be more capable than its predecessors to cause infection in people who have been vaccinated for COVID or have been previously infected with SARS-CoV-2. The U.S. Centers for Disease Control and Prevention (CDC) said that, due to the high number of mutations detected in this new SARS-CoV-2 strain, it may be more efficient at evading immunity from vaccines and previous infections.7

The federal health agency abruptly stopped tracking breakthrough infections, or instances of vaccine failure in 2021, choosing to only include data on breakthrough infections that result in hospitalizations and deaths.8 Newer COVID booster shots, which COVID vaccine manufacturers and health officials claim will prevent serious complications from infection with an Omicron subvariant known as XBB.1.5, are expected to be available by the end of this month.9 10

If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here.

Click here to view References:

1 Baker A. U.S. to Spend Billions on New COVID Vaccines Despite Failure to Prevent Infection. The Vaccine Reaction Apr. 23, 2023.
2 Press Release. Project NextGen Awards Over $1.4 Billion to Develop the Future of COVID-19 Vaccines and Therapeutics. U.S. Department of Health and Human Services, Aug. 22, 2023.
3 Satija B et al. Pfizer considers cost cuts as demand for COVID products falls. Reuters Aug. 1, 2023.
4 Jefferson T, Dooley L et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database of Systematic Reviews 2023; 1.
5 Useem J, Brennan A, LaValley M, Vickery M, Ameli O, Reinen N, Gill CJ. Systematic Differences between Cochrane and Non-Cochrane Meta-Analyses on the Same Topic: A Matched Pair Analysis. PLoS One Dec. 15, 2015; 10(12): e0144980.
6 Francois Balloux, [@BallouxFrancois]. Jan. 30, 2023. X.
7 Jain P. US CDC says new COVID lineage could cause infections in vaccinated individuals. Reuters Aug. 23, 2023.
8 Stein R. CDC Move to Limit Investigations Into COVID Breakthrough Infections Sparks Concerns. NPR June 2, 2021.
9 Reubein R et al. CDC under fire for decision to limit tracking of Covid-19 cases in vaccinated people. Politico July 30, 2021.
10 Benadjaoud Y. Government spending $1.4 billion to study new and improved COVID vaccines, despite low uptake. ABC News Aug. 24, 2023.

Biden To Request Funds From Congress For New COVID Vaccine

Biden To Request Funds From Congress For New COVID Vaccine

US President Joe Biden speaks to the press after attending a pilates class in South Tahoe, California, on August 25, 2023. (Photo by Mandel NGAN / AFP) (Photo by MANDEL NGAN/AFP via Getty Images)
US President Joe Biden speaks to the press after attending a pilates class in South Tahoe, California, on August 25, 2023. (Photo by MANDEL NGAN/AFP via Getty Images)

OAN’s Roy Francis
9:56 AM – Saturday, August 26, 2023


Republished below in full unedited for informational, educational, & research purposes.

President Joe Biden said on Friday that he plans to request more funding from Congress in order to develop a new COVID vaccine.

Biden says he just "signed off" on a funding request for "a new [COVID] vaccine is necessary that works,"

“I signed off this morning on a proposal we have to present to the Congress a request for additional funding for a new vaccine that is necessary, that works,” Biden told reporters while vacationing in Lake Tahoe. “It will likely be recommended that everybody get it no matter whether they’ve gotten it before or not.”

The announcement comes after reports of a recent rise in COVID-19 cases in some regions of the country. Due to the recent reports of a rise in hospitalizations, mask mandates are also slowly being reintroduced by some organizations, such as LionsGate studios.

Updated versions of the vaccine which contain the newer version of the virus are already being developed by Pfizer, Novavx, and Moderna. Officials claim that due to the mutating nature of the virus, the vaccine needs to constantly be updated.

The supplemental funding that the Biden administration recently presented to Congress did not include any funding for COVID-19 vaccines. Instead, the request asked for around $40 billion for short-term “key priorities” such as more aid for Ukraine, federal disaster funds, climate change, and a minimal amount for border security.

In the fall of 2022, Biden had also asked for around $9 billion from Congress for funding for the virus, but the request was denied by Congress at the time.

Stay informed! Receive breaking news blasts directly to your inbox for free. Subscribe here.

There’s More Bad News for the Covid-Vaccinated

Whew Boy… There’s More Bad News for the Covid-Vaccinated

Whew Boy… There’s More Bad News for the Covid-Vaccinated
AP Photo/Charles Krupa, File
Congratulations, everyone! It’s time for another COVID variant! Did you think having already been vaccinated and boosted was gonna get you through this one? Think again!

The U.S. Centers for Disease Control and Prevention (CDC) reported on Wednesday that the emerging BA.2.86 COVID-19 variant could potentially lead to infections in those who not only had COVID before but have previously been vaccinated.

“The large number of mutations in this variant raises concerns of greater escape from existing immunity from vaccines and previous infections compared with other recent variants,” the CDC stated in its risk assessment summary for this new lineage of COVID. “For example, one analysis of mutations suggests the difference may be as large as or greater than that between BA.2 and XBB.1.5, which circulated nearly a year apart.”

Related: Biden Challenged Us to Name One of His Failures. Here Are 8 Big Ones.

Are you scared yet? Well, maybe the CDC will just have to try harder.

Americans have largely gotten over COVID at this point, with only a select few still too paranoid to ditch the masks. I can’t remember the last time I saw someone wearing a mask in public. Even the Biden administration quietly admitted the pandemic was over back in April. At this point, most of the population has acquired COVID-19 antibodies. There’s a reason why deaths and hospitalizations are way, way, way down, and people have long resumed living life normally again and are looking back at the lockdowns and the months of masking with disgust. But with an eerie sense of déjà vu, it feels like we’re once again in the thick of the pandemic and being conditioned to believe something terrible is on the horizon and we have to do something about it.

And the CDC is on it!

“Based on what CDC knows now, existing tests used to detect and medications used to treat COVID-19 appear to be effective with this variant,” the CDC explains. However, there’s a rather interesting and significant caveat to this. According to the CDC, “Scientists are evaluating the effectiveness of the forthcoming, updated COVID-19 vaccine.”

And there it is! A new updated vaccine is in the works. If you thought life was back to normal because you got vaccinated and got boosted every month, you better put your tail back between your legs and sign up to get another updated version of the vaccine. Those Big Pharma profits won’t make themselves, after all.

Rand Paul: We Now Have the ‘Smoking Gun’~Dr. Anthony Fauci now referred to the [Department of Justice] for criminal investigation, accused of lying under oath to Congress about his knowledge of the U.S.-funded COVID research in Wuhan.

Dr. Anthony Fauci now referred to the [Department of Justice] for criminal investigation, was accused of lying under oath to Congress about his knowledge of the U.S.-funded COVID research in Wuhan. … He said, adamantly, that the government never did this gain-of-function research. We now have the Government Accountability Office, and the GAO, has admitted that the funding came from the NIH. We have the acting director, [Lawrence] Tabak, of the NIH admitting in writing that it came from NIH. But now, really, we have the smoking gun, and that is Fauci in private saying the opposite of what he was saying in public when he was publicly telling me that, absolutely, we did not fund gain-of-function research in China.

This Steams My Clams: Ivermectin Is Suddenly OK for COVID?

This Steams My Clams: Ivermectin Is Suddenly OK for COVID?
Pat Wellenbach
Perhaps a doctor can prescribe a gasoline enema for the Food and Drug Administration (FDA). A lawyer for the FDA recently declared doctors may now — years after it’s needed — prescribe ivermectin for COVID-19. Just in time!

Now that the nation is down to a mere 205 COVID deaths per week, and the pharmaceutical-industrial complex has hoovered billions of dollars in cheddar while Americans watched loved ones die on hospital ventilators via Facetime after tens of thousands of people have suffered adverse effects from the vaccine clot-shot — now the FDA claims it’s always been cool for doctors to give their patients a cheap drug many folks knew helped people with the Bat-stew flu.

Oh really? Roll the tape.

FACT-O-RAMA! The punchinellos at the FDA beclowned themselves by tweeting, “You are not a horse. You are not a cow. Seriously, y’all. Stop it,” after podcaster and comedian Joe Rogan announced ivermectin helped him overcome COVID. Never mind that the FDA approved ivermectin for human consumption decades earlier.

Some bozos at the FDA were tickled pinko when their embarrassing tweet went viral.

Look at this whopper of a lie on the FDA’s website:

COVID-19. We’ve been living with it for what sometimes seems like forever. Given the number of deaths that have occurred from the disease, it’s perhaps not surprising that some consumers are turning to drugs not approved or authorized by the Food and Drug Administration (FDA).

I guess the jackpuddings at the FDA “forgot” ivermectin was cleared for humans in 1987.

Let’s take a quick walk down memory lane and reveal some of the commies who tried to scare us away from a cheap, effective medicine to fight COVID.

“Never use medications intended for animals on yourself or other people. Animal ivermectin products are very different from those approved for humans. Use of animal ivermectin for the prevention or treatment of COVID-19 in humans is dange rous.”

University of Kansas:

“Ivermectin shown ineffective in treating COVID-19, according to multi-site study including KU Medical Center.”

The American Medical Association:

“Taking a drug for an unapproved use can be very dangerous and misinformation that says it is OK to take ivermectin for COVID-19—or in large doses—is wrong, the FDA consumer update warns. Even approved levels of ivermectin can interact with other medications such as blood thinners. Overdose of ivermectin can also cause nausea, vomiting, diarrhea, hypotension, allergic reactions, dizziness, ataxia, seizures, coma and even death.”

Dr. Anthony Fauci:

‘Don’t do it’: Dr. Fauci warns against using ivermectin to treat or prevent COVID-19

I could add squawking heads from the Communist News Network (CNN) and the rest of the Pravda Press, but I’m sure you get the point.

So why did the FDA lawyer claim doctors have always had the right to prescribe ivermectin?

Three doctors sued the feds over the FDA’s “right” to dictate how physicians treat their patients. All three claim they were fired for trying to prescribe ivermectin for their patients, which they say is because the FDA warned people against ivermectin, a notion the FDA now denies.

“The fundamental issue in this case is straightforward,” the doctors’ attorney, Jared Kelson, declared in court. “After the FDA approves the human drug for sale, does it then have the authority to interfere with how that drug is used within the doctor-patient relationship? The answer is no.”

Ashley Cheung Honold, a Department of Justice (DOJ) lawyer representing the FDA, claims the agency never said doctors couldn’t prescribe ivermectin.

“What about when it said, ‘No, stop it’?” Circuit Judge Jennifer Walker Elrod asked Honold, referring to the aforementioned tweet. “Why isn’t that a command? If you were in English class, they would say that was a command.”

In response, Honold fell on her clown sword and stated that those words were “merely quips.”

Related: Unfollow the Science: 300 COVID Articles Pulled, Many Over Lack of Ethical Standards

I suspect the truth is this: there was too much money on the table for the pharmaceutical-industrial complex to lose. Ivermectin costs pennies. How can Pfizer fat cats line their pockets and throw some cheddar back at Democrats who helped them rake it in on a cheap drug like ivermectin?

Heartbroken Dad Exposes Hospital COVID Protocols He Believes Killed His Teenage Daughter

Heartbroken Dad Exposes Hospital COVID Protocols He Believes Killed His Teenage Daughter
AP Photo/Natacha Pisarenko)
The unfortunate reality in 2023 is that unless you’re literally on death’s door, out of options, or you require emergency care for an acute injury such as severe trauma, a mainline American hospital — especially one run by a large institution dependent on government dollars — may not be the ideal place to turn if you care about you or your family’s health.

Some might disagree with that sentiment or dismiss it as hyperbole — but certainly not this dad who claims that a Wisconsin hospital killed his daughter with its COVID protocols.

Via The Defender (the publication wing of RFK Jr.’s Children’s Defense Fund):

“I miss her immensely.”

Those are the words of Scott Schara, father of Grace Naomi (Emily) Schara, who died on Oct. 13, 2021, at age 19 at Ascension St. Elizabeth Hospital in Appleton, Wisconsin.

Grace died just days after she tested positive for COVID-19 and went to an urgent care facility where she was treated for low oxygen levels.

Before reading further, I already foresaw the unfortunate subsequent series of events before they appeared to me in the text, as they are not novel: the doctors, prodded by the hospital administrators through policy edicts, threw this girl on a ventilator before they even gave her lungs and heart a fighting chance to up her oxygen levels on their own, potentially with the help of medication.


Grace’s ordeal began on Oct. 1, 2021, when she tested positive for COVID-19 using a home testing kit. Five days later, her oxygen saturation had dropped to 88% as shown on the pulse oximeter her parents purchased in accordance with the Front Line COVID-19 Critical Care Alliance’s (FLCCC) COVID-19 treatment protocol.

According to the protocol, hospitalization is recommended if oxygen saturation drops below 94%. Schara, however, now questions this recommendation.

“I’m not throwing FLCCC under the bus at all, but the fear propaganda influenced my critical thinking,” he said. “If you’re going to start measuring something, you’ve got to know what to measure against, not a number someone throws out.”

“What I’ve learned subsequently is when a person catches a cold or flu, their oxygen saturation naturally drops,” Schara said. He recounted being hospitalized with COVID-19 and low blood oxygen levels around the same time as his daughter, at a different hospital where he “just about died.”

It is well-documented that – even according to the most hardline Branch COVIDians like CNN’s resident Public Health™ propagandist, Leana Wen – that not only were COVID deaths overcounted, but hospitals were financially incentivized by the government to toss patients onto ventilators as often as possible.

Right now Medicare is determining that if you have a COVID-19 admission to the hospital you get $13,000. If that COVID-19 patient goes on a ventilator you get $39,000, three times as much. Nobody can tell me after 35 years in the world of medicine that sometimes those kinds of things impact on what we do.
-Dr. Scott Jensen, practicing physician

Via WJAR 10 (NBC):

Under the CARES Act passed by Congress earlier this year, Medicare, which covers Americans over age 65, pays hospitals up to 20% more for some types of high-cost care that patients with severe COVID-19 may need. That includes things like putting a patient on a ventilator and a longer total time spent in the hospital.

In addition to the financial incentives, a hospital full of patients on respirators serves as magnificent COVID fear fodder to peddle on corporate state media in the service of continuing forced masking, forced vaxing, and lockdowns in perpetuity.

Continuing via The Defender:

According to Schara, Grace was administered Precedex, a sedative produced by Pfizer “that should never be used with COVID.” However, “they use it because their goal with COVID is dollars and the main dollars are for getting somebody on a ventilator — and they have to be sedated to be put on a ventilator,” he said.

“They asked my wife and I five different times for a pre-authorization to put Grace on a ventilator,” Schara said. “We never approved it, nor should anybody approve a ventilator when somebody has a COVID diagnosis. A ventilator has a 90% kill rate with COVID, so why do it? And it’s simply because of the financial incentives.”

1 2 3 58